It is likely that our data did not reach statistical significance because of the small sample size.
← all excerpts
Soluble Guanylate Cyclase Stimulators (Riociguat) in Pulmonary Hypertension: Data from Real-Life Clinical Practice in a 3-Year Follow-Up.
1
—
—